Blood CancerPhase 2NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors
A Phase 2 study testing Cancer: Thriving and Surviving Online Workshop in people with Blood Cancer and Breast Cancer, run by Stanford University at 2 sites in 2 countries.
Trial summary
Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Blood Cancer, Breast Cancer, Prostatic Neoplasms
- What is being tested?
- Cancer: Thriving and Surviving Online Workshop
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 585 participants
- Where
- 2 sitesin 2 countries
- Study dates
- Jul 2009to Dec 2011
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Inclusion Criteria:Any adult (19 and over) cancer survivor living in the United States who: 1) was diagnosed within the past 5 years with a new or recurring cancer since the original diagnosis; 2) has completed their cancer treatment (surgery, radiation and/or chemotherapy); 3) isn't currently being treated for cancer except for hormonal therapy; and 4) has and email account and access to high speed internet connection. Exclusion Criteria:Not meeting the inclusion criteria
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
United States1 site
Stanford University School of Medicine
Stanford, California, 94305
About this study
Official title: Cancer Survivors Online Self-Management Workshop
Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life.
Read the detailed description
This workshop is aimed at helping you better manage your own health and the demands placed on you because of your cancer diagnosis. It is hoped that the workshop will give you the skills needed to reduce stress and improve your quality of life. If successful, the workshop can be made available to other cancer survivors.
Each workshop is 6 weeks with new lessons each week. You will be asked to log on at your convenience 2-3 times each week for a total of 1-2 hours, to read the lessons, complete assignments, and share your ideas and experiences with your classmates. There are no requirements that participants log in at the same time.
With the moderators and other workshop participants, you will discuss:
- Healthy eating
- Managing fatigue
- Managing stress
- Starting and maintaining an appropriate physical activity program
- Getting a good night's sleep
- Dealing with difficult emotions
- Solving the problems caused by having had cancer
- Communicating better with your health care professionals
- Communicating better with your friends, family and coworkers
- Being tested
- Cancer: Thriving and Surviving Online Workshop
- Medical subject headings
- Hematologic Neoplasms, Breast Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cancer: Thriving and Surviving Online WorkshopBehavioural
| Study group | Role | What they receive |
|---|---|---|
| online workshop | Experimental | Not described Receives: Behavioral: Cancer: Thriving and Surviving Online Workshop |
What is being measured
The primary outcome is the main question the study is designed to answer.
Document patterns of health care utilization
Measured: 2011
Quality of Life
Measured: baseline and 6 months
Outcome Measure: Better Interactions with Oncologists
Measured: baseline and 6 months
Health Behaviors
Measured: baseline and 6 months
Secondary outcomes (1)
Satisfaction with intervention
Measured: baseline and 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Aug 2009 (estimated)
- Study startJul 2009
- Primary completionAug 2011
- Study completionDec 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Blood CancerStudies of the same condition, open and under way.
- More trials run by Stanford UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 585 participants (actual)
Sponsor and investigators
- Lead sponsor
- Stanford University
- Sponsor type
- University, hospital or other
- Collaborators
- University of Hawaii Cancer Research Center
- Responsible party
- Principal investigator, Kate Lorig, Stanford University
- Investigators
- Kate R Lorig, Principal investigator, Stanford University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00962494
- Sponsor's protocol ID
- VAR0044
- Other IDs
- SU-07292009-3460
- Status last verified
- Feb 2013
- First submitted
- 18 Aug 2009
- Last updated
- 7 Feb 2013
- Results posted
- No
Publications
Bantum EO, Albright CL, White KK, Berenberg JL, Layi G, Ritter PL, Laurent D, Plant K, Lorig K. Surviving and thriving with cancer using a Web-based health behavior change intervention: randomized controlled trial. J Med Internet Res. 2014 Feb 24;16(2):e54. doi: 10.2196/jmir.3020.
PubMed 24566820
Study at a glance
From the registry record, last updated by the sponsor on 7 Feb 2013. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cancer Survivors Online Self-Management Workshop
- ClinicalTrials.gov ID
- NCT00962494
- Acronym / sponsor ID
- VAR0044
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 585 participants (actual)
- Lead sponsor
- Stanford UniversityUniversity, hospital or other
- Collaborators
- University of Hawaii Cancer Research Center
- Study start
- Jul 2009
- Primary completion
- Aug 2011 (actual)
- Study completion
- Dec 2011 (actual)
- First posted
- 20 Aug 2009 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cancer: Surviving and Thriving is a 6-week workshop for cancer survivors. The overall goal of the study is to determine whether an online cancer survivor education and support workshop can have lasting beneficial effects in helping survivors improve their self-management of health skills and quality of life.
Detailed description
This workshop is aimed at helping you better manage your own health and the demands placed on you because of your cancer diagnosis. It is hoped that the workshop will give you the skills needed to reduce stress and improve your quality of life. If successful, the workshop can be made available to other cancer survivors.
Each workshop is 6 weeks with new lessons each week. You will be asked to log on at your convenience 2-3 times each week for a total of 1-2 hours, to read the lessons, complete assignments, and share your ideas and experiences with your classmates. There are no requirements that participants log in at the same time.
With the moderators and other workshop participants, you will discuss:
- Healthy eating
- Managing fatigue
- Managing stress
- Starting and maintaining an appropriate physical activity program
- Getting a good night's sleep
- Dealing with difficult emotions
- Solving the problems caused by having had cancer
- Communicating better with your health care professionals
- Communicating better with your friends, family and coworkers
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| online workshop | Experimental | Behavioral: Cancer: Thriving and Surviving Online Workshop |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cancer: Thriving and Surviving Online Workshop | Behavioural | online workshop |
Primary outcome
Document patterns of health care utilization
Time frame: 2011
Quality of Life
Time frame: baseline and 6 months
Outcome Measure: Better Interactions with Oncologists
Time frame: baseline and 6 months
Health Behaviors
Time frame: baseline and 6 months
1 secondary outcome
Satisfaction with intervention
Time frame: baseline and 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Feb 2013.
- Derived from this study: PubMed 24566820Bantum EO, Albright CL, White KK, Berenberg JL, Layi G, Ritter PL, Laurent D, Plant K, Lorig K. Surviving and thriving with cancer using a Web-based health behavior change intervention: randomized controlled trial. J Med Internet Res. 2014 Feb 24;16(2):e54. doi: 10.2196/jmir.3020.
Related trials for Blood Cancer
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Active, not recruitingPhase 3
A Phase III Study of Eque-cel in Subjects With Len-refractory RRMM (FUMANBA-03)
Multiple Myeloma
Active, not recruitingPhase 1/2
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Multiple Myeloma
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kate R Lorig principal investigator
Stanford University
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Cancer: Thriving and Surviving Online Workshop in people with Blood Cancer and Breast Cancer, run by Stanford University at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Feb 2013. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States, United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Document patterns of health care utilization (time frame: 2011). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00962494, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2013.